Jennifer B. Green, MD

Articles by Jennifer B. Green, MD

Authors’ Reply to “Comment on Generalizability of GLP-1 RA CVOTs in US T2D Population”

ByEric T. Wittbrodt, PharmD, MPH,James M. Eudicone, MS, MBA,Kelly F. Bell, PharmD, MSPhr,Devin M. Enhoffer, PharmD,Keith Latham, PharmD,Jennifer B. Green, MD

April 8th 2019

The authors of the manuscript “Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population” respond to a letter to the editor.

Eligibility Varies Among the 4 Sodium-Glucose Cotransporter-2 Inhibitor Cardiovascular Trials: Implications for the General Type 2 Diabetes US Population

ByEric T. Wittbrodt, PharmD, MPH,James M. Eudicone, MS, MBA,Kelly F. Bell, PharmD, MSPhr,Devin M. Enhoffer, PharmD,Keith Latham, PharmD,Jennifer B. Green, MD

April 13th 2018

Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population

ByEric T. Wittbrodt, PharmD, MPH,James M. Eudicone, MS, MBA,Kelly F. Bell, PharmD, MSPhr,Devin M. Enhoffer, PharmD,Keith Latham, PharmD,Jennifer B. Green, MD

April 13th 2018

Jennifer B. Green, MD

Articles by Jennifer B. Green, MD

Authors’ Reply to “Comment on Generalizability of GLP-1 RA CVOTs in US T2D Population”

Eligibility Varies Among the 4 Sodium-Glucose Cotransporter-2 Inhibitor Cardiovascular Trials: Implications for the General Type 2 Diabetes US Population

Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population

Latest Updated Articles

Trending on AJMC

Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home

Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

CAR T Therapy Likely the Next Frontier for Treating Patients With MG: James F. Howard, MD